Otsuka Holdings
4578.T
#747
Rank
C$43.16 B
Marketcap
C$81.74
Share price
0.21%
Change (1 day)
0.35%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

P/E ratio for Otsuka Holdings (4578.T)

P/E ratio as of December 2025 (TTM): 19.3

According to Otsuka Holdings 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 19.2714. At the end of 2024 the company had a P/E ratio of 13.4.

P/E ratio history for Otsuka Holdings from 2010 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202413.4-41.58%
202323.038.1%
202216.7-1.1%
202116.813.94%
202014.8-20.62%
201918.6-27.73%
201825.826.36%
201720.4-18.42%
201625.032.65%
201518.8116.07%
20148.72-20.72%
201311.0-1.49%
201211.221.55%
20119.19

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.